Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 2

Conditions

Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Myelodysplastic Syndromes 1

Interventions

Specimen Handling 22fludarabine 20Cyclophosphamide 19Biopsy 19fludarabine phosphate 15Cytarabine 13Whole-Body Irradiation 11Busulfan 11venetoclax 10Tacrolimus 10Mycophenolic Acid 10Melphalan 10X-Rays 9decitabine and cedazuridine drug combination 8asciminib 8Magnetic Resonance Spectroscopy 8Injections 8Granulocyte Colony-Stimulating Factor 7Cyclosporine 7Azacitidine 7ruxolitinib 6Thiotepa 6Sirolimus 6Nuclear Medicine Department, Hospital 6Stem Cell Transplantation 5Phantoms, Imaging 5Peripheral Blood Stem Cell Transplantation 5Idarubicin 5Filgrastim 5CPX-351 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liposomes × Myeloid × 30 days × Clear all
NCT05554406 2026-06-05

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Recruiting
335 enrolled
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT05564390 2026-06-05

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

National Cancer Institute (NCI)

Phase 2 Recruiting
2,000 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡